News
Press Releases
September 3, 2025
BlueWhale Bio Announces First Patient Dosed in Clinical Trial Using Synecta™ T1 Cell-Derived Nanoparticles
September 7, 2023
BlueWhaleBio Founded with $18M Financing led by Danaher Ventures to Accelerate Cell Therapy Manufacturing
Media Coverage
September 10, 2025
Pharmaceutical Technology: Kytopen and BlueWhale Bio partner for cell therapy innovation
September 5, 2025
Philadelphia Business Journal: Carl June’s BlueWhale company achieves major milestone with its cell therapy platform
September 8, 2023
Philadelphia Business Journal: Penn spinout founded by Carl June emerges from stealth mode with $18M in funding
September 7, 2023
Fierce Biotech: BlueWhale Bio surfaces with $18M on mission to overhaul cell therapy production
